Novel TORC1 inhibitor Ecl1 is regulated by phosphorylation in fission yeast
Aging Cell · 2025
DOI: 10.1111/acel.14450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Hokuto Ohtsuka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Laboratory of Molecular Microbiology, Tokai National Higher Educa…. Hauptthemen laut MEDLINE: Schizosaccharomyces, Schizosaccharomyces pombe Proteins, Mechanistic Target of Rapamycin Complex 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Extender of chronological lifespan 1 (Ecl1) inhibits target of rapamycin complex 1 (TORC1) and is necessary for appropriate cellular responses to various stressors, such as starvation, in fission yeast. However, little is known about the effect of posttranslational modifications on Ecl1 regulation. Thus, we investigated the phosphorylation levels of Ecl1 extracted from yeast under conditions of sulfur or metal starvation. Mass spectrometry analysis revealed that Ecl1 was phosphorylated at Thr7, and the level was decreased by starvation. The phosphorylation‐mimetic mutation of Thr7 significantly reduced the effects of Ecl1‐induced cellular responses to starvation, suggesting that Ecl1 function was suppressed by Thr7 phosphorylation. By contrast, regardless of starvation exposure, TORC1 was significantly suppressed, even when Thr7 phosphorylation‐mimetic Ecl1 was overexpressed. This indicated that Ecl1 suppressed TORC1 regardless of Thr7 phosphorylation. We newly identified that Ecl1 physically interacted with TORC1 subunit RAPTOR (Mip1). Based on these evidences, we propose that, Ecl1 has dual functional modes: quantity‐dependent TORC1 inhibition and Thr7 phosphorylation–dependent control of cellular function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medicinal Sciences, Graduate School of Pharmaceutical Sciences, Laboratory of Molecular Microbiology, Tokai National Higher Education and Research System, Nagoya University, Nagoya, Japan.
- Department of Chemistry and Biochemistry, Suzuka College, National Institute of Technology (KOSEN), Suzuka, Japan.
- Department of Biology, Graduate School of Science, Osaka City University, Osaka, Japan.
- Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan.
- Life Science Network, The University of Tokyo, Tokyo, Japan.
- Institute of Transformative bio-Molecules, Tokai National Higher Education and Research System, Nagoya University, Nagoya, Japan.
ORCID-Profile: Hokuto Ohtsuka, Takafumi Shimasaki, Kazuki Imada, Yoko Otsubo, Akira Yamashita, Emi Mishiro-Sato, Hirofumi Aiba
Förderung
- JSPS KAKENHI
Zitieren
APA
Ohtsuka, H., Kawai, S., Ito, Y., Kato, Y., Shimasaki, T., Imada, K., Otsubo, Y., Yamashita, A., Mishiro-Sato, E., Kuwata, K., & Aiba, H. (2025). Novel TORC1 inhibitor Ecl1 is regulated by phosphorylation in fission yeast. Aging Cell. https://doi.org/10.1111/acel.14450
Vancouver
Ohtsuka H, Kawai S, Ito Y, Kato Y, Shimasaki T, Imada K, et al. Novel TORC1 inhibitor Ecl1 is regulated by phosphorylation in fission yeast. Aging Cell. 2025. doi:10.1111/acel.14450
BibTeX
@article{Ohtsuka2025,
author = {Ohtsuka, Hokuto and Kawai, Sawa and Ito, Yurika and Kato, Yuka and Shimasaki, Takafumi and Imada, Kazuki and Otsubo, Yoko and Yamashita, Akira and Mishiro-Sato, Emi and Kuwata, Keiko and Aiba, Hirofumi},
title = {Novel TORC1 inhibitor Ecl1 is regulated by phosphorylation in fission yeast},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.14450}
}
EUVIMED